Assessment of the IgG Trough Level in Subjects With Primary Immunodeficiency Switching From Standard Subcutaneous Immunoglobulin (SCIG) to Every Other Week HyQvia
Phase of Trial: Phase IV
Latest Information Update: 25 Aug 2017
At a glance
- Drugs Immune globulin (Primary)
- Indications Immunodeficiency disorders
- Focus Pharmacokinetics
- 21 Aug 2017 Status changed from not yet recruiting to recruiting.
- 20 Feb 2017 Planned initiation date changed from 1 Sep 2016 to 1 Jun 2017.
- 16 Sep 2016 New trial record